LWBK1006-15 LWW-Govindan-Review December 7, 2011 19:5
168 DeVita, Hellman, and Rosenberg’s CANCER: Principles and Practice of Oncology Review
Question 15.32. Regarding breast MRI, which is TRUE?
A. Not useful in the postoperative breast.
B. More specific than sensitive in neoplasm detection.
C. Intravenous contrast is not needed.
D. Obviates need for biopsy.
E. Impact on mortality has yet to be determined.
Question 15.33. Regarding colorectal cancer, which is TRUE?
A. CT colography is limited by reliance on intravenous contrast.
B. Transrectal ultrasound (TRUS) is a useful way of evaluating the entire
colon.
C. MDCT is an accurate way to evaluate the bowel wall tumor exten-
sion.
D. MRI is better than CT in the evaluation of distant metastasis.
E. MRI is a more sensitive way to assess localized disease extension than
MDCT.
Question 15.34. Regarding gynecologic malignancies, which is TRUE?
A. Transabdominal ultrasound is the first step in staging endometrial
cancer.
B. CT is limited in the assessment of localized extension of cervical
cancer.
C. MRI is more sensitive than MDCT for detecting myometrial invasion
of cervical cancer.
D. MRI is much better than MDCT in detecting lymphadenopathy from
gynecologic malignancies.
Question 15.35. Regarding cervical cancer, which is TRUE?
A. Ultrasound is a highly effective way to stage cervical cancer.
B. MRI is a more effective technique for evaluating parametrial invasion
than CT.
C. CT is an effective staging tool for localized disease.
D. No role for PET in the staging of cervical cancer.
Question 15.36. Regarding ovarian cancer, which is NOT true?
A. Ultrasound is an effective method for distinguishing ovarian from
uterine lesions.
B. MRI is superior to ultrasound in determining whether an adnexal
lesion is malignant.
C. CT and MRI are better than ultrasound for the detection of peritoneal
disease.
D. MRI is better than CT for detection of lymphadenopathy from ovar-
ian cancer.